Clint recently had the opportunity to chat with Rob MacNaughton, the CEO of Calibrate, about the groundbreaking approach his company is taking in the weight loss industry by combining powerful GLP-1 drugs like Wegovy and Ozempic with clinician-led lifestyle interventions. Rob shares insights into the advantages and disadvantages of these medications, the impressive results Calibrate has achieved, and the importance of addressing the root causes of obesity. We also delve into Rob's diverse background, the challenges and benefits of leading a fully remote company, and the role of AI in enhancing member experience and operational efficiency. Timestamps: 00:00 - Introduction 00:09 - Rob's background and the rise of GLP-1 drugs 01:03 - Calibrate's unique approach to weight loss 02:29 - Impressive results and published data 04:00 - Safety and efficacy of GLP-1 drugs 05:14 - What a typical week looks like for Calibrate members 07:19 - Rob's journey to Calibrate 12:36 - The importance of addressing the root cause of obesity 14:25 - A day in the life of a remote CEO 16:35 - Leadership in a remote environment 19:39 - Talent acquisition in a remote setting 23:00 - The role of AI in Calibrate's operations 26:03 - Long-term planning with AI 27:10 - The importance of giving and taking chances